Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taishiro Kishimoto

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 14, 2023
Will digital technology address the challenges of drug development in psychiatry?Taishiro Kishimoto
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|January 9, 2019
[Studying the Efficacy of Long-acting Injectable Antipsychotics (LAI) While Considering Study Design Limitations : A Discussion in Favor of LAI]Taishiro Kishimoto
Lancet (London, England)|October 7, 2023
Decline in Japan's research capabilities: challenges in the medical fieldShotaro Kinoshita, Taishiro Kishimoto
The Lancet. Psychiatry|September 22, 2023
The use of a national identification system to prevent misuse of benzodiazepines and Z-drugs in JapanShotaro Kinoshita, Taishiro Kishimoto
JMA Journal|November 8, 2024
Updating the Japanese Healthcare System to Meet the Needs of an Aging SocietyShotaro Kinoshita, Taishiro Kishimoto
The Lancet. Diabetes & Endocrinology|January 25, 2024
Anti-obesity drugs, eating disorders, and thinness among Japanese young womenShotaro Kinoshita, Taishiro Kishimoto
Journal of Medical Internet Research|January 20, 2025
Japan's Telepsychiatry Dissemination: Current Status and ChallengesShotaro Kinoshita, Taishiro Kishimoto
The Lancet Regional Health. Western Pacific|January 30, 2025
Challenges introduced by Japan's drug pricing policyShotaro Kinoshita, Taishiro Kishimoto
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|December 17, 2021
Current Status and Challenges of the Dissemination of Telemedicine in Japan After the Start of the COVID-19 PandemicShotaro Kinoshita, Taishiro Kishimoto
The Lancet. Psychiatry|October 13, 2022
Is this the end of precision medicine? Or the beginning?Akihiro Takamiya, Taishiro Kishimoto
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 14, 2023
Will digital technology address the challenges of drug development in psychiatry?Taishiro Kishimoto
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|January 9, 2019
[Studying the Efficacy of Long-acting Injectable Antipsychotics (LAI) While Considering Study Design Limitations : A Discussion in Favor of LAI]Taishiro Kishimoto
Lancet (London, England)|October 7, 2023
Decline in Japan's research capabilities: challenges in the medical fieldShotaro Kinoshita, Taishiro Kishimoto
The Lancet. Psychiatry|September 22, 2023
The use of a national identification system to prevent misuse of benzodiazepines and Z-drugs in JapanShotaro Kinoshita, Taishiro Kishimoto
JMA Journal|November 8, 2024
Updating the Japanese Healthcare System to Meet the Needs of an Aging SocietyShotaro Kinoshita, Taishiro Kishimoto
The Lancet. Diabetes & Endocrinology|January 25, 2024
Anti-obesity drugs, eating disorders, and thinness among Japanese young womenShotaro Kinoshita, Taishiro Kishimoto
Journal of Medical Internet Research|January 20, 2025
Japan's Telepsychiatry Dissemination: Current Status and ChallengesShotaro Kinoshita, Taishiro Kishimoto
The Lancet Regional Health. Western Pacific|January 30, 2025
Challenges introduced by Japan's drug pricing policyShotaro Kinoshita, Taishiro Kishimoto
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|December 17, 2021
Current Status and Challenges of the Dissemination of Telemedicine in Japan After the Start of the COVID-19 PandemicShotaro Kinoshita, Taishiro Kishimoto
The Lancet. Psychiatry|October 13, 2022
Is this the end of precision medicine? Or the beginning?Akihiro Takamiya, Taishiro Kishimoto
Pageof 18